Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
Scientific Reports|July 22, 2015
Novel Cathelicidins from Pigeon Highlights Evolutionary Convergence in Avain Cathelicidins and Functions in Modulation of Innate ImmunityHaining Yu, Yiling Lu, Xue Qiao, et al.
Oncology Reports|August 10, 2017
Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail‑glycolysis pathwaysLuoqi Jia, Jiayi Zhou, Hongbo Zhao, et al.
Oncogene|April 12, 2002
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityDimpy Koul, Samar A Jasser, Yiling Lu, et al.
Plos One|April 3, 2010
Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinaseZhiyong Ding, Jiyong Liang, Jin Li, et al.
The Journal of Biological Chemistry|October 27, 2004
Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signalingXiao-Feng Le, Amy Lammayot, David Gold, et al.
Gynecologic Oncology|September 4, 2019
Identification and validation of a prognostic proteomic signature for cervical cancerJanet S Rader, Amy Pan, Bradley Corbin, et al.
Nature Communications|April 5, 2018
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancersDaniel J McGrail, Lorenzo Federico, Yongsheng Li, et al.
Journal of the National Cancer Institute|November 13, 2008
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cellsShuangxing Yu, Mandi M Murph, Yiling Lu, et al.
Seminars in Oncology|November 13, 2003
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancerGordon B Mills, Elise Kohn, Yiling Lu, et al.
Plos One|December 16, 2014
Spatial normalization of reverse phase protein array dataPoorvi Kaushik, Evan J Molinelli, Martin L Miller, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Scientific Reports|July 22, 2015
Novel Cathelicidins from Pigeon Highlights Evolutionary Convergence in Avain Cathelicidins and Functions in Modulation of Innate ImmunityHaining Yu, Yiling Lu, Xue Qiao, et al.
Oncology Reports|August 10, 2017
Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail‑glycolysis pathwaysLuoqi Jia, Jiayi Zhou, Hongbo Zhao, et al.
Oncogene|April 12, 2002
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityDimpy Koul, Samar A Jasser, Yiling Lu, et al.
Plos One|April 3, 2010
Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinaseZhiyong Ding, Jiyong Liang, Jin Li, et al.
The Journal of Biological Chemistry|October 27, 2004
Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signalingXiao-Feng Le, Amy Lammayot, David Gold, et al.
Gynecologic Oncology|September 4, 2019
Identification and validation of a prognostic proteomic signature for cervical cancerJanet S Rader, Amy Pan, Bradley Corbin, et al.
Nature Communications|April 5, 2018
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancersDaniel J McGrail, Lorenzo Federico, Yongsheng Li, et al.
Journal of the National Cancer Institute|November 13, 2008
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cellsShuangxing Yu, Mandi M Murph, Yiling Lu, et al.
Seminars in Oncology|November 13, 2003
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancerGordon B Mills, Elise Kohn, Yiling Lu, et al.
Plos One|December 16, 2014
Spatial normalization of reverse phase protein array dataPoorvi Kaushik, Evan J Molinelli, Martin L Miller, et al.
Pageof 23